SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : CELSION CORP. (CLN was CELN) UP $.33 TO $.59 ON HUGE NEWS -- Ignore unavailable to you. Want to Upgrade?

To: Jay D. who wrote (397)2/16/1999 1:16:00 PM
From: Dave Gore  Read Replies (2) | Respond to of 518
 
results of human trials... or conclusion of PHASE 1..actaully could be much longer than a few weeks, maybe a few months of course...then we will know if we have a real compnay here with potential.

But a decent speculation here....under $1.00



To: Jay D. who wrote (397)3/4/1999 10:39:00 AM
From: Dave Gore  Respond to of 518
 
"Our current BPH system is positioned to notably expand the $9 billion
worldwide market for BPH treatment by encouraging more men to seek
treatment, especially those with moderate symptoms," stated CELN
President and CEO Spencer Volk. "We expect the current clinical studies
to confirm the 'walk-in be treated, walk-out with total relief' nature
of our out-patient BPH system.

From today's Press Release


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News